Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Phosphoinositide Interacting Protein Coordinates Stress Precursor Activities

ABSTRACT: Samd14 coordinates stem cell factor/Kit receptor signaling and is crucial for the survivalof red blood cel precursors within anemia contexts. Here we present new findings that Samd14 expression is needed to maintain balanced autophagy in red blood cell precursors following acute anemia. Autophagy gene signatures and protein levels are markedly altered withinthe context of acute anemia when red blood cell precursors accelerate the process of erythropoiesis. Samd14 interacted via its SAM domain with phosphatidylinositol 3-phosphate (PI3P) which is an integral component of endosomal and autophagic membranes. We tested PI3Ps role in red blood cell differentiation using a small molecule inhibitor of the Class III PI 3-kinase VPS34, which is the sole kinase responsible for PI3P genesis. SAR405 treatment blocked red blood cell formation. In the absence of Samd14, higher doses of VPS34 inhibition were required to block erythroid differentiation. Given the critical roles of autophagy in normal differentiation, Samd14’s stress-dependent activation and roles in autophagy suggest that this mechanism is needed to maintain progenitor levels and balance the production of healthy, mature red blood cells.

INSTRUMENT(S):

ORGANISM(S): Anemia Mus Musculus (mouse)

TISSUE(S): Spleen

SUBMITTER: Sophe Alvarez

LAB HEAD: Sophie Alvarez

PROVIDER: PXD067716 | Pride | 2026-02-11

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20230310_SR_phTMTpro.msf	Msf
	20230310_SR_phTMTpro_FT10all-NH3_40-60-80.raw	Raw
	20230310_SR_phTMTpro_FT10all-NH3_50-70-90.raw	Raw
	20230310_SR_phTMTpro_NH3_10pc_40-60-80.raw	Raw
	20230310_SR_phTMTpro_NH3_10pc_50-70-90.raw	Raw

Items per page:

1 - 5 of 26

Similar Datasets

Regeneration Alters Open Chromatin and Cis-Regulatory Landscape of Erythroid Precursors

Project description:Stress erythropoiesis elevates the rate of red blood cell (RBC) production as a physiological response to stressors such as anemia or hypoxia. To identify cis-regulatory changes that underlie anemia-specific gene expression and cellular responses, we analyzed chromatin accessibility in populations of cells enriched for red blood cell precursors isolated from mice at a range of time points after anemia induction. The representation of red blood cell trait-associated loci in ATAC-seq data remained durably elevated more than 1 month after anemia resolution. Together, these findings provide a framework to understand the early establishment and late resolution of a regeneration-dependent transcriptome in RBC progenitors and precursors.

2025-03-24 | GSE275430 | GEO

In vitro reconstitution of Sgk3 activation by phosphatidylinositol-3-phosphate

Project description:Serum- and glucocorticoid-regulated kinase 3 (Sgk3) is activated by the phospholipid 19 phosphatidylinositol-3-phosphate (PI3P) downstream of growth factor signaling and 20 by Vps34-mediated PI3P production during autophagy. Upregulation of Sgk3 activity 21 has been linked to a number of human cancers due to its overlapping substrate 22 specificity with Akt. Here, we show that Sgk3 is regulated by a combination of 23 phosphorylation and allosteric activation by PI3P. We demonstrate that Sgk3 is 24 specifically activated by PI3P and that PI3P binding induces large conformational 25 changes in Sgk3. Using Vps34 and liposomes containing phosphatidylinositol, we 26 reconstitute Sgk3 signaling via Vps34-mediated PI3P synthesis in vitro. In addition to 27 defining the mechanism of Sgk3 activation by PI3P, our findings open up potential 28 therapeutic avenues in allosteric inhibitor development to target Sgk3 in cancer.

2021-09-22 | PXD025327 | Pride

Drug Discovery For Diamond Blackfan Anemia Using Reprogrammed Hematopoietic Progenitors

Project description:Diamond-Blackfan anemia (DBA) is a congenital disorder characterized by the failure of erythroid progenitor differentiation, severely curtailing red blood cell production. Because many DBA patients fail to respond to corticosteroid therapy, there is considerable need for therapeutics for this disorder. Identifying therapeutics for DBA requires circumventing the paucity of primary patient blood stem and progenitor cells. To this end, we adopted a reprogramming strategy to generate expandable hematopoietic progenitor cells from induced pluripotent stem cells (iPSCs) from DBA patients. Reprogrammed DBA progenitors recapitulate defects in erythroid differentiation which were rescued by gene complementation. Unbiased chemical screens identified SMER28, a small molecule inducer of autophagy, which enhanced erythropoiesis in a range of in vitro and in vivo models of DBA. SMER28 acted through autophagy factor ATG5 to stimulate erythropoiesis and upregulate expression of globin genes. These findings present an unbiased drug screen for hematological disease using iPSCs and identify autophagy as a therapeutic pathway in DBA.

2017-01-01 | GSE90940 | GEO

ULK1/2 DKO MEF phosphoproteomics

Project description:Autophagy is a mechanism by which intracellular cargo are catabolised in the lysosome. It involves the formation of double membraned organelles termed autophagosomes, a complex process orchestrated by the serine/threonine kinase ULK complex and class III PI3 kinase VPS34. Unbiased screens for ULK substrates revealed that the phosphoproteome is significantly altered upon loss of Ulk1/2 and yielded a high confidence list of substrates, including VPS34 complex member VPS15 and AMPK complex member PRKAG2. We identified 6 new ULK substrate residues in the VPS15. Mutation of these VPS15 phosphoacceptors reduces autophagosome formation and autophagic flux in cells, and VPS34 activity in vitro. ULK phosphorylation of the major phosphosite in VPS15, serine 861, decreases both autophagy initiation and autophagic flux. Analysis of VPS15 knockout cells and the ULK substrate VPS34 serine 249 revealed two novel ULK-dependent phenotypes downstream of VPS15 removal: starvation-independent accumulation of ULK substrates and kinase activity-regulated recruitment of autophagy proteins to ubiquitin-positive structures, both of which occur upon VPS15 ablation and can be partially recapitulated by chronic VPS34 inhibition.

2021-06-15 | PXD022228 | Pride

Parp-2 is required for efficient erythropoiesis in mice by limiting replicative stress in erythroid progenitors

Project description:Erythropoiesis is a tightly regulated process in which multipotential hematopoietic stem cells give rise to mature red blood cells. Here, we show that Parp-2 deficiency in mice leads to chronic anemia, despite increased EPO plasma levels, providing a novel role for Parp-2 in erythropoiesis. Loss of Parp-2 causes shortened red blood cells lifespan and impaired differentiation of erythroid cells. Transcriptomic analyses revealed the activation of the p53-dependent-DNA damage response pathways on Parp-2-deficient erythroblasts, triggering the expression of genes involved in cell cycle checkpoints and apoptosis. Accordingly, Parp-2-deficient erythroblasts shows G2/M cell cycle arrest and increased apoptosis.

2014-12-31 | GSE54864 | GEO

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Project description:RATIONALE: Epoetin alfa may stimulate red blood cell production and treat anemia in patients with cancer who are receiving chemotherapy. It is not yet known whether epoetin alfa is more effective than a placebo in treating anemia in patients receiving chemotherapy. PURPOSE: Randomized double blinded phase III trial to compare the effectiveness of epoetin alfa with a placebo in treating anemia in cancer patients who are receiving chemotherapy.

| 2003109 | ecrin-mdr-crc

A Congenital Anemia Dissociates the Pleiotropic Functions of Master Transcription Factor GATA1 [Patient_RNAseq]

Project description:Master regulators, such as the hematopoietic transcription factor GATA1, have numerous roles in lineage commitment and differentiation. While human GATA1 mutations result in several blood diseases, all characterized mutations act relatively early to impair hematopoietic differentiation. Here, we describe a distinct form of hemolytic anemia involving impaired terminal erythropoiesis with a reduced lifespan of circulating red blood cells. We show that this unique blood disorder results from mutations in a poorly characterized and intrinsically disordered C-terminal region of GATA1.

2021-12-31 | GSE133414 | GEO

A Congenital Anemia Dissociates the Pleiotropic Functions of Master Transcription Factor GATA1 [G1E_ChIPseq]

2021-12-31 | GSE133409 | GEO

A Congenital Anemia Dissociates the Pleiotropic Functions of Master Transcription Factor GATA1 [G1E_ATACseq]

2021-12-31 | GSE133404 | GEO

A Congenital Anemia Dissociates the Pleiotropic Functions of Master Transcription Factor GATA1 [G1E_RNAseq]

2021-12-31 | GSE133403 | GEO